Background: Gestational weight gain (GWG) is a modifiable risk factor for obesity in women. Black women have the greatest prevalence of high body mass, which predisposes them to excessive GWG. Increased understanding of genetic influences on GWG has implications for the health of women. The purpose of this study was to explore the associations of GNB3 and FTO risk alleles in pregnant women with prepregnancy body mass index (BMI), GWG, and postpartum and infant birth weights. Research design and Methods: This was an observational, prospective candidate gene association study. Pregnant, lowincome Black women (N ¼ 97) were enrolled in early pregnancy and followed until 6 months postpartum. Results: GWG differed depending on number of FTO risk alleles. The mean 6-month postpartum BMI differed, although not significantly, by 4 kg/m 2 between homozygous women. There was an interaction between the FTO risk allele and prepregnancy BMI (p ¼ .022), with obese homozygote AA women having significantly higher mean GWG than obese TT women. When controlling for age and smoking, the FTO gene and physical activity predicted GWG (p ¼ .032). Although not statistically significant, women who carried the GNB3 T risk allele gained 6 pounds more than noncarriers, and mean 6-month postpartum BMI differed by 2.2 kg/m 2 between homozygous women. Neither the GNB3 nor FTO gene predicted prepregnancy BMI, infant birth weight, or postpartum weight. Conclusion: Obese women homozygous for the FTO risk allele were at greater risk of excessive GWG compared to nonrisk allele homozygous obese women or nonobese women. This study provides evidence of the FTO gene's effect on GWG in Black women.
Obesity is a growing epidemic that threatens the morbidity and mortality of women. The weight gained with childbearing contributes to this obesity epidemic and disease risk (Gunderson et al., 2009) . Excessive gestational weight gain (GWG), as categorized according to Institute of Medicine (IOM) recommendations, and prepregnancy body mass index (BMI) are known contributors to postpartum weight retention (Rasmussen & Yaktine, 2009 ). Over 50% of pregnant women in the United States gain more weight than the IOM recommends (Simas et al., 2011) and therefore are at increased risk of long-term obesity, which is associated with negative health consequences such as hypertension, cardiovascular disease, diabetes mellitus, and osteoarthritis (Centers for Disease Control and Prevention, 2011) . The IOM recommends a reduction in targeted GWG as a woman's prepregnancy BMI increases, so that women with a prepregnancy BMI < 18.5 kg/m 2 should have GWG of 28-40 pounds, those with a prepregnancy BMI of 18.5-24.9 kg/m 2 should gain 25-35 pounds, those with a prepregnancy BMI of 25-29.9 kg/m 2 should gain 15-25 pounds, and those with a prepregnancy BMI ! 30 kg/m 2 should gain 11-20 pounds (Rasmussen & Yaktine, 2009 ).
The racial/ethnic group in the United States with the highest prevalence of overweight/obesity is Black women (Flegal, Carroll, Kit, & Ogden, 2012) . Over 82% of Black women are overweight or obese and nearly 59% are obese. Furthermore, over 33% of low-income Black women are obese prior to pregnancy (Hinkle et al., 2012) . Prepregnancy obesity increases the risk of pregnancy complications (Nohr et al., 2005; Robinson, O'Connell, Joseph, & McLeod, 2005) and poor pregnancy outcomes such as maternal (Huda, Brodie, & Sattar, 2010) and infant (Ruager-Martin, Hyde, & Modi, 2010) metabolic complications, infants who are small for gestational age, and preterm birth. In addition, offspring of mothers who are obese are at increased risk of childhood overweight (Whitaker, 2004) .
Low-income Black women experience more weight-related risks postpartum (e.g., weight retention and overweight/obesity) than low-income White women (Walker, Fowles, & Sterling, 2011) . In fact, GWG has a long-term effect on BMI increase in Black women 18 years after a first pregnancy (Groth, Holland, Meng, & Kitzman, 2013) . Additionally, Black women consistently deliver more low-birth weight (LBW) infants than White women, even with similar GWGs (Caulfield, Witter, & Stoltzfus, 1996; Schieve, Cogswell, & Scanlon, 1998) .
Genetic variants linked to excessive GWG, a modifiable risk factor for obesity in women, could be markers for metabolic disease (Stuebe et al., 2010) . Two genome-wide association studies (GWAS) have assessed obesity and diabetes genes during pregnancy (Lawlor et al., 2011; Stuebe et al., 2010) . Taken together, their conclusions are equivocal. Stuebe and colleagues (2010) cited evidence that several diabetes and obesity risk alleles are associated with GWG, with some of these alleles interacting with maternal prepregnancy BMI to predict GWG. Conversely, Lawlor et al.'s (2011) investigation in the United Kingdom indicated that obesity-related risk genes are not associated with GWG. These two studies differed in sample size (N ¼ 960 and N ¼ 6,426, respectively) and, possibly, composition (diverse sample of Caucasian and African American women vs. racial diversity not reported, respectively). Additionally, the researchers calculated GWG differently, with Stuebe et al. defining GWG as the difference between prepregnancy weight and final weight before delivery and Lawlor et al. defining it as weight change calculated for three time points across pregnancy. This difference resulted in different statistical modeling of GWG.
Candidate gene association studies of the GNB3 C825 T (rs5443) single nucleotide polymorphism (SNP) suggest an association of the T risk allele with GWG (Dishy et al., 2003) , postpartum weight retention (Gutersohn, Naber, Muller, Erbel, & Siffert, 2000) , and LBW (Hocher et al., 2000) . One study suggested that women homozygous for the T allele are more likely to retain weight in the first year postpartum when physical activity level is less than 1 hr/week compared with women whose physical activity level is more than 1 hr/week (Gutersohn et al., 2000) . In the nonpregnant population, this SNP appears to interact with physical activity (Grove et al., 2007; Gutersohn et al., 2000; Hauner, Meier, Jockel, Frey, & Siffert, 2003) . It has also been associated with hypertension (Dong et al., 1999; Schunkert, Hense, Doring, Riegger, & Siffert, 1998; Siffert et al., 1998) , obesity (Danoviz, Pereira, Mill, & Krieger, 2006; Grove et al., 2007) , and metabolic syndrome (Siffert, 2005) in the nonpregnant population. A cross-sectional study that examined this SNP and physical activity in an African American sample reported a significant interaction between the T allele and physical activity on obesity (Grove et al., 2007) ; there was a 20% reduction in obesity for each T allele and, conversely, with low levels of physical activity, obesity prevalence increased by 23%. Worldwide measurement of distribution of the 825 T allele indicates that the percentage of distribution in the United States for Blacks is approximately 70-72% (Siffert et al., 1999) . A second report indicates worldwide frequencies of 82% in Africans and 30% in Caucasians (Rosskopf et al., 2002) .
Of the obesity-related genes, FTO (rs9939609) has been studied to a greater extent than the others. The A allele is the risk allele, and for heterozygotes (AT), there appears to be an intermediate effect (Frayling et al., 2007; Song et al., 2008) . Findings from extended studies suggest that the FTO gene affects insulin resistance (Do et al., 2008; Legry et al., 2009) and is associated with type 2 diabetes (Ng et al., 2008; Yajnik et al., 2009 ) and increased risk of gestational diabetes mellitus (Cho et al., 2009; Freathy et al., 2008; Huopio et al., 2013; Lauenborg et al., 2009; Yajnik et al., 2009 ). Furthermore, the FTO gene appears to influence eating patterns (Sonestedt et al., 2009; Tanofsky-Kraff et al., 2009; Timpson et al., 2008) and interact with physical activity (Andreasen et al., 2008; Sonestedt et al., 2009 ). It has also been associated with GWG in thin and obese Caucasian women homozygous for the high-risk allele (Stuebe et al., 2010) . In pregnant women from the United Kingdom, it has been associated with prepregnancy weight and BMI (Lawlor et al., 2011) .
Genetic effects on behavior and health may differ across the life course. The myriad of biological and behavioral changes that occur during pregnancy can compound these genetic influences (Wehby & Scholder, 2013) . Given the long-term detrimental effects of excessive GWG, increasing our understanding of genetic influences on GWG, a modifiable risk factor for obesity, has implications for the health of women. The purpose of this study was to explore the associations of GNB3 and FTO risk alleles in pregnant Black women with prepregnancy BMI, GWG, postpartum weight, and infant birth weight.
Materials and Methods

Design and Sample
This study was an observational, prospective candidate gene association study. Following university institutional review board approval, we enrolled 97 pregnant low-income Black women from obstetrical clinics associated with the university medical center in upstate New York that predominantly serve low-income women. We recruited women from the clinic sites using flyers, plus clinic staff offered potential participants information about the study at the time of an appointment. We followed the women from prior to 20 weeks' gestation to 6 months postpartum. Women were included if they were over 18 years of age and entered prenatal care prior to 20 weeks' gestation. Because multiple fetuses influence total GWG and the recommendations for GWG are provisional in these cases and differ from those of singleton pregnancies (Rasmussen & Yaktine, 2009 ), we limited participation to women with singleton pregnancies. We also limited participation to women whose prepregnancy BMIs fell between 18.5 kg/m 2 and 40.0 kg/m 2 . Though the IOM GWG recommendations for obese women are meant to apply to all women whose BMIs put them into the obese category, data are limited for supporting application to women at the highest obesity levels. In addition, the prevalence of underweight women in the population from which we drew our sample is small, and those women are unlikely to gain excessively during pregnancy (Rasmussen & Yaktine, 2009 ). We excluded women who had a medical or psychiatric condition that could preclude informed consent or a medical condition that could influence weight gain or loss (e.g., diabetes, gastrointestinal problems, and hypertension treated with medications).
Measures
After informed consent was completed, we collected saliva samples for DNA analysis along with baseline data, including demographic characteristics, prepregnancy or early pregnancy weight, height, and whether women reported smoking during pregnancy, dichotomized as yes/no. We used prepregnancy weight if there was a recent weight in the medical record (within 3 months prior to pregnancy); otherwise, we used the first weight recorded in the medical record after the initiation of prenatal care, adjusting it downward if it had been measured after 14 weeks' gestation (see subsequently). We calculated prepregnancy BMI using the weight abstracted from the medical record and the height measurement that we collected at baseline (kg/m 2 ). Prior to 22 weeks' gestation (i.e., baseline), at 24-29 weeks' gestation, at 32-37 weeks' gestation, and at 6 weeks and 6 months postpartum, we collected weight and self-reported physical activity level, either at the clinical research center (CRC) at the university medical center or via phone. Data were collected by CRC staff and the project coordinator. We abstracted pregnancy and delivery data from the medical records, including changes in social and behavioral factors (e.g., smoking and financial status) and final weight before delivery, along with newborn weight.
We calculated GWG by subtracting the prepregnancy/early pregnancy weight from the final weight before delivery. Though the amount of weight gain in the first trimester is usually relatively small (1 kg; Rasmussen & Yaktine, 2009) , if the first weight that we had for a participant was obtained after 14 weeks' gestation, we adjusted the weight downward by the estimated average weekly GWG during the second trimester of pregnancy (Rasmussen & Yaktine, 2009 ) in order to avoid underestimating total GWG.
We used the Pregnancy Physical Activity Questionnaire (PPAQ) to collect data on physical activity during pregnancy. The instrument has been tested in pregnant women and has high reliability (r ¼ .78-.93) and established validity (Chasan-Taber et al., 2004) . The PPAQ consists of 36 items asking participants to report the amount of time they spent on 32 different activities during the current trimester including inactivity, household/caregiving activities, occupational, and sports/exercise activities. It is scored by multiplying duration of time spent on the activity by intensity to obtain a METhr/week score, which is average weekly energy expenditure, a continuous variable. Furthermore, activities can be classified by type (i.e., household/caregiving, occupational, and sports/ exercise) and also by intensity (light, moderate, and vigorous).
Genetic Data
We used Oragene DNA self-collection kits (DNA Genotek Corporation, Ottawa, Canada) to collect saliva samples at the time of study enrollment. After ascertaining that the women had not had anything to eat for 30 min, study staff asked them to spit into the collection tube until 2 ml of saliva had been obtained. Staff then sealed the container, labeled it with a participant identification number, and stored it at room temperature until laboratory analysis. The saliva was purified using the prepIT-L2P plate purification protocol from DNA Genotek. The extracted DNA was then quantified on a NanoDrop 1000 spectrophotometer and normalized to 15 ng/ul for SNP genotyping. We used 30 ng for each polymerase chain reaction (PCR). Samples were run in single reactions for each FTO and GNB3 TaqMan SNP genotyping assay. TaqMan Universal PCR Master Mix (No AmpErase UNG) and TaqMan SNP genotyping assays were plated automatically into a 384-well plate using the CAS 1200 robotics system. The real-time PCR reaction was run on Applied BioSystem's (Life Technologies) 7900HT real-time instrument using the software SDS 2.4.1 (ABI 7900HT, Sequence Detection Systems version 2.4.1, Applied Biosystems Foster City, CA, USA). Immediately after the real-time PCR finished, a post read was completed. SDS 2.4.1 was also used to perform analysis and auto-call genotypes.
Data Analysis
We used Statistical Package for the Social Sciences version 20.0 for data analysis. Descriptive statistics calculated included means, standard deviations, frequencies, and percentages. Comparisons of GWG, infant birth weight, and 6-month postpartum weight among gene allele combinations were made using Student's t-test. BMI was a continuous variable for all analyses, and standard categories of underweight (BMI < 18.5 kg/m 2 ), normal weight (BMI ¼ 18.5-24.9 kg/m 2 ), overweight (BMI ¼ 25.0-29.9 kg/m 2 ), and obese (BMI ! 30 kg/m 2 ) were used to categorize prepregnancy BMI.
Following bivariate analyses of all demographic variables and their relationships to prepregnancy BMI, GWG, infant birth weight, and 6-month postpartum BMI, linear regression models were used to explore differences based on genotype (controlling for age, parity, and smoking), with prepregnancy BMI, GWG, infant birth weight, and 6-month postpartum BMI as outcome variables. Level of significance was set at p < .05. Simple effects analysis was used to examine the FTO gene effect on GWG for women in each of the prepregnancy BMI categories.
Associations among the FTO gene, physical activity, and GWG were estimated using linear regression. We used three models that included physical activity for each of the three measurement time points during pregnancy. Covariates described previously were initially included in the models. However, the overall models were not significant with all covariates, so nonsignificant terms with the highest p values were removed until model significance was reached.
Results
The sample included 97 women, of which 89% delivered at term (!37 weeks' gestation). Maternal age ranged from 18 to 36, and more than two thirds of the women were multiparous (Table 1) . Not all women consistently returned to the CRC for all data collection points, resulting in variation in the amount of data available at each time point. At 6 months postpartum, we collected the final follow-up data from 61 women. The remainder of the sample was no longer eligible due to miscarriages or fetal deaths, lost to follow-up (e.g., hard to reach due to disconnected telephones and moved), or did not keep their appointments. Mean GWG was 31.5 pounds, while two women who were obese prior to pregnancy lost weight. Among those who gained weight during pregnancy, the GWG ranged from 7 to 87 pounds. The SNP genotyping distribution for the GNB3 and FTO alleles is provided in Table 2 . There was no deviation from Hardy-Weinberg equilibrium (GNB3 w 2 ¼ .09, df ¼ 1, p ¼ .76; FTO w 2 ¼ 2.15, df ¼ 1, p ¼ 0.14). Of the initial bivariate analyses to determine the relationship of demographic factors with GWG, only age and parity were predictive of GWG (p ¼ .017 and p ¼ .006, respectively). Bivariate models examining demographics and outcomes of prepregnancy BMI, infant birth weight, and 6-month postpartum BMI were not significant.
Association Between GNB3 Genotype and Prepregnancy BMI, GWG, Infant Birth Weight, and 6-Month Postpartum BMI Comparison of mean GWG among women with different GNB3 alleles suggests that heterozygotes (TC) were similar to the risk allele homozygotes (TT; Table 2 ). Mean GWG for CT/TT women was 6 lb higher than for CC women. However, this difference was not significant (p ¼ .363). When we compared women homozygous for the risk allele (TT) to women without the risk allele (CC), the relationship remained nonsignificant (p ¼ .295). There was also no significant difference in 6-month postpartum BMI between genotypes, though women homozygous for the risk T allele had a mean BMI of 2.2 kg/m 2 higher than that of women homozygous for the C allele. The relationships between genotype and prepregnancy BMI and infant birth weight were also not significant.
Association Between FTO Genotype and Prepregnancy BMI, GWG, Infant Birth Weight, and 6-Month Postpartum BMI GWG differed depending on number of FTO A alleles (Table 2) . Women with two risk alleles (AA) gained more weight than women with a single or no risk allele. There was a nonsignificant difference when carriers of the risk allele (AT/AA) were compared to women with no risk allele (TT; p ¼ .17). When we compared homozygotes (AA vs. TT), we found that the difference in GWG was not significant (p ¼ .051).
FTO risk alleles were not associated with prepregnancy BMI. Nevertheless, we tested for an interaction between FTO risk alleles and prepregnancy BMI based on previous reports of an interaction effect (Stuebe et al., 2010) . In addition, the mean GWG differed among all women in each prepregnancy BMI category: normal weight ¼ 35 lb, overweight ¼ 35.1 lb, and obese ¼ 27 lb. Heterozygous women were excluded due to the apparent intermediate effect of a single risk allele on weight gain. There was a significant interaction between the FTO risk alleles and prepregnancy BMI for homozygous women (Table 3 ). Subgroup analysis of prepregnancy BMI categories showed a significant difference between the mean GWG of homozygotes for the A risk allele and that of homozygotes for the T allele in obese women (t ¼ 3.03; p ¼ .009); homozygotes (n ¼ 8) for the A risk allele gained 41.5 lb (SD ¼ 15.8), as compared to T homozygotes (n ¼ 8), who gained 19 lb (SD ¼ 13.9). Yet there was not a statistically significant difference between these women in BMI at 6 months postpartum based on genotype (TT women ¼ 35.8 kg/m 2 , AA women ¼ 40.0 kg/m 2 ; p ¼ .18). In our linear regression models estimating the influence of the FTO gene and physical activity on GWG, the variables age, total physical activity, and FTO (AA or TT) remained in the final model for the early pregnancy time point and explained 16.5% of the variance in GWG, F(3, 36) ¼ 3.58; p ¼ .023. When we controlled for age, the FTO gene (homozygotes only) predicted GWG (b ¼ À13.48; p ¼ .007) and physical activity was not significant (b ¼ .053; p ¼ .062). Similarly, at the mid-pregnancy time point, the initial model that included physical activity was not significant. The model reached statistical significance when FTO, age, smoking, and physical activity were retained (p ¼ .032), with the variables explaining 24.4% of the variance in GWG (Table 4 ). When we controlled for age and smoking, the FTO gene (homozygotes only) and physical activity predicted GWG. The model that included physical activity late in pregnancy did not reach statistical significance. There was no interaction between physical activity and the FTO homozygotes in any of the models tested.
Discussion
Our finding of an interaction between the FTO gene and prepregnancy BMI suggests that obese women homozygous for the A risk allele are at greater risk of excessive GWG than both obese women who do not carry the risk allele and nonobese women who carry the risk allele. The mean GWG for obese women homozygous for the risk allele (AA) was 22.5 lb greater than that of obese women homozygous for the nonrisk allele (TT). This finding is consistent with that of Stuebe et al. (2010) , who reported an increased risk of excessive GWG in obese White women who were carriers of the FTO risk allele. Our findings suggest that excessive GWG may have contributed to longer term BMI increases for homozygous obese women carrying the FTO risk alleles since their mean BMI at 6 months postpartum was 4.2 kg/m 2 higher than that of obese women homozygous for the nonrisk alleles. If so, these women have an increased risk of the long-term negative health consequences associated with obesity.
There appeared to be an intermediate effect of the FTO risk allele on GWG, a finding similar to that of Stuebe et al. (2010) also among African American women. However, in this study, we did not find an intermediate effect of the FTO risk allele on prepregnancy BMI, as did Lawlor et al. (2011) . However, Lawlor et al.'s sample was from the United Kingdom, and the authors did not specify racial/ethnic composition. Though not reaching statistical significance (p ¼ .051), our finding that GWG may differ between women homozygous for the risk allele (AA) and those homozygous for the nonrisk allele (TT) suggests that there may be an effect of the FTO gene 30.1 (5.9) 30.6 (7.3) 27.9 (11.5) 30.3 (7.9) 31.8 (6.2) 31.5 (5.1)
Note. BMI ¼ body mass index; GWG ¼ gestational weight gain. Data are for women with full-term deliveries only. Data are presented as mean (SD) unless otherwise indicated.
on GWG in Black women that could be detected in a larger sample.
In our linear regression models examining the effects of the FTO gene on GWG, incorporating mid-pregnancy physical activity into the model and controlling for age and smoking explained the greatest amount of variance in GWG (24.4%). Levels of physical activity were highest earlier in pregnancy and declined from early to late pregnancy among our participants, which is consistent with the literature regarding physical activity levels during pregnancy (Currie et al., 2013; Pereira et al., 2007) . Yet in this study, mid-pregnancy is the one time point where physical activity had an effect on GWG. Interestingly, the relationship between mid-pregnancy physical activity and GWG was not in the expected negative direction. As physical activity (MET-hr/week) increased, GWG also increased. One possible explanation for this finding is that the level of physical activity in these women may have been too low to counteract the typical weight gain of pregnancy, which, at mid-pregnancy, is an average of 1 lb/week. Alternatively, our finding that two thirds of the homozygous women who had a measure of physical activity at midpregnancy were homozygous for the risk allele (AA) may indicate that the genetic influence of this risk allele was stronger than the impact of physical activity on GWG. In bivariate analyses, physical activity was not an independent predictor of GWG, and the FTO gene neared significance, suggesting that there may be an interaction effect that could be detected in a larger sample.
In this study, the GNB3 gene was not significantly related to prepregnancy BMI, GWG, infant birth weight, or 6-month postpartum BMI, nor was there an interaction with physical activity during pregnancy. Yet, we did document a nonsignificant 6-lb difference in mean GWG between women homozygous for the TT versus CC alleles, suggesting that there may be a relationship between the GNB3 gene and GWG. No previous studies have investigated the GNB3 C825 T gene in Black women in relation to GWG. In a similar study of White nulliparous women, researchers found that the GNB3 gene and GWG were significantly related (Gutersohn et al., 2000) . In that study, researchers compared the TC/CC combination to homozygous TT women. In the present sample, GWG in TC women was more similar to that in TT women than to GWG in CC women, thus it would not have been helpful to combine the sample in a similar manner.
The limitations of this study warrant consideration. The findings are limited to Black women and cannot be generalized to a larger population. The sample size is relatively small for a genetic study and reduced our ability to detect differences among women with different genotypes. However, we did find associations specific to the FTO gene consistent with what has been reported in the literature in other populations (Lawlor et al., 2011; Stuebe et al., 2010) . By including only homozygotes in our statistical models, we were able to identify differences not seen when the intermediate effect of heterozygotes was present. Findings related to the GNB3 gene were limited by the small number of women homozygous for the nonrisk allele, though we did observe a nonsignificant difference in GWG by genotype. Furthermore, our results on 6-month postpartum BMI were questionable due to the limited sample size of GNB3 CC and FTO TT women at that time point (n ¼ 4).
Conclusion and Implications for Clinical Practice
In this study, we found that obese Black women homozygote for the FTO risk allele were at greater risk of excessive GWG compared to either obese Black women homozygous for the nonrisk allele or nonobese Black women. Furthermore, in models examining the effects of the FTO gene on GWG, the addition of physical activity in mid-pregnancy improved the model's predictive ability for GWG.
Research has shown that obese women are at greater risk of gaining excessive weight during pregnancy (Rasmussen & Yaktine, 2009 ), but the mechanisms are not known. The knowledge gained from this study that excessive GWG could be related to FTO risk allele status, as opposed to behavioral influences alone, can help to guide how nurses approach and manage GWG in obese women. The opportunity to create specific GWG guidelines for obese women homozygous for the FTO risk allele could improve management of their GWG and consequently decrease their pregnancy-related health risks. The possibility of predicting which obese women are more likely to gain excessively during pregnancy could allow nurses and other care providers to offer improved targeted guidance on GWG for each woman, thereby improving outcomes for both mother and infant. Prior research has shown that personal health planning, or individual guidance, is effective for weight reduction among postpartum women following excessive GWG (Yang, Wroth, Parham, Strait, & Simmons, 2013) ; therefore, individual guidance based on genetic information may be useful during pregnancy to prevent excessive weight gain. Black women report a need for information on appropriate GWG and safe physical activity during pregnancy (Shieh & Weaver, 2011) . Nurses could provide this information and guidance based on genetic predisposition.
Physical activity, specifically during mid-pregnancy, influenced GWG in this study, but not as expected. Further research is warranted to understand the relationship of physical activity with the FTO gene as well as the clinical relevance of this relationship with GWG. Physical activity may affect GWG in different ways depending on genetic risk, but it is recommended for all women during pregnancy (American College of Obstetricians and Gynecologists, 2002) and improves pregnancy outcomes (Currie et al., 2013) . Prior work suggests that lowincome women would welcome the opportunity to learn from care providers how to increase their physical activity (Yeo & Logan, 2014) . Nurses are well positioned to motivate pregnant women and provide information on how they can stay active.
Efforts to detect genetic associations for complex disease entities such as obesity have proved challenging, with a relatively small amount of the overall genetic risk of obesity being explained. The risk alleles that have been identified in
